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Abstract
Plumbagin, a quinonoid found in the plants of the Plumbaginaceae, possesses medicinal properties. In this study we
investigated the anti-proliferative and apoptotic activity of plumbagin by using two human colonic cancer cell lines, HT29
and HCT15. IC50 of Plumbagin for HCT15 and HT29 cells (22.5 mM and 62.5 mM, respectively) were significantly different. To
study the response of cancer cells during treatment strategies, cells were treated with two different concentrations, 15 mM,
30 mM for HCT15 and 50 mM, 75 mM for HT29 cells. Though activation of NFkB, Caspases-3, elevated levels of TNF-a,
cytosolic Cytochrome C were seen in both HCT15 cells HT29 treated with plumbagin, aberrant apoptosis with decreased
level of pEGFR, pAkt, pGsk-3b, PCNA and Cyclin D1was observed only in 15 mM and 30 mM plumbagin treated HCT15 and
75 mM plumbagin treated HT29 cells. This suggests that plumbagin induces apoptosis in both HCT15 cells and HT29 treated,
whereas, proliferation was inhibited only in 15 mM and 30 mM plumbagin treated HCT15 and 75 mM plumbagin treated
HT29 cells, but not in 50 mM plumbagin treated HT29 cells. Expression of COX-2 was decreased in 75 mM plumbagin treated
HT29 cells when compared to 50 mM plumbagin treated HT29 cells, whereas HCT15 cells lack COX. Hence the observed
resistance to induction of apoptosis in 50 mM plumbagin treated HT29 cells are attributed to the expression of COX-2. In
conclusion, plumbagin induces apoptosis in colonic cancer cells through TNF-a mediated pathway depending on
expression of COX-2 expression.
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Introduction
Colorectal cancer (CRC) is a primary public health concern to
the humankind and is the third most common cancer in the
United States [1]. Recent data on colorectal cancer is alarming
with an estimated 153,760 cases of CRC including 52,180 deaths
in 2007 [1,2]. Progression from normal colonic epithelial cells into
a colorectal carcinoma is a multistep process. Even though there
many factors such as, loss or mutation in tumor suppressor genes,
epigenetic alterations controlling cell survival, cell proliferation
and angiogenesis, inflammation play a crucial role in CRC
development and progression [3–8].
NF-kB is a key inflammatory mediator involved in initiation,
progression and metastasis of CRC [9]. A variety of carcinogens
and tumor promoters have been shown to activate NF-kB and
constitutive expression of NF-kB is frequently found in tumor cells.
Several genes involved in tumor initiation, promotion, and
metastasis are regulated by NF-kB as well as activation of NF-
kB suppresses apoptosis and promotes proliferation. Hence, agents
that can down-regulate the activation of NF-kB therefore, would
have the potential to inhibit development of cancer.
Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone), a quino-
noid, found in the plants of the Plumbaginaceae, Droseraceae,
Ancestrocladaceae, and Dioncophyllaceae families. The Chief
source of Plumbagin is the root of Plumbago zeylanica L. (also known
as ‘‘Chitrak’’). Plumbagin has been shown to exert anticarcino-
genic, antiatherosclerotic and antimicrobial effects [10–13]. The
root of P. zeylanica L. has been used in Indian medicine for ,2,750
years and its component possess antiatherogenic, cardiotonic,
hepatoprotective and neuroprotective properties [11].
Sugie etal.[14] haveshown thatplumbaginsignificantly inhibited
azoxymethane-induced intestinal carcinogenesis in rats, suggesting
its chemopreventive activity. Plumbagin has also been shown to
induce S-G2/M cell cycle arrest through the induction of p21 (an
inhibitor of cyclin-dependent kinase) [15]. Recent studies showed
that Plumbagin induces apoptosis through inhibition of NF-kBi n
various cancer cell lines including human chronic myeloid leukemia,
human multiple myeloma, human embryonickidneycarcinomaand
Breast cancer cells [16,17]. In this study, we examined the anti-
proliferative and apoptotic activity of plumbagin by in vitro
experimental models using two human colonic cancer cell lines,
HT29and HCT15.Further, themechanism of anticancer activityof
plumbagin was established by analysing cell cycle regulation and
signalling molecules related to cell survival and apoptosis.
Materials and Methods
Cell culture and maintenance
Human colon tumor cell lines HT29 and HCT15 were
obtained from NCCS Pune. Cells were grown in Dulbeccos
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supplemented with 10% FBS (Sigma, USA), 100 units/ml
Penicillin, 100 mg/ml Streptomycin, 10–20 mg/ml fungisone
(Himedia, India), pH 7.4 in 25 cm
2, tissue culture flasks (Himedia,
India) at 37uC under 5% CO2 and 95% air.
Treatment
Plumbagin was purchased from Sigma. A 100 mM solution of
plumbagin was prepared in dimethyl sulfoxide (DMSO), stored as
small aliquots at 220uC and then diluted as needed in cell culture
medium. Dose-response studies were carried out to determine the
suitable dose for the inhibition of cell growth and induction of
apoptosis.
MTT assay
Sensitivity of HT29 and HCT15 cells to plumbagin was
determined by the MTT colorimetric assay [18]. Cells (1610
3 per
well) were seeded in a flat-bottomed 96-well plate and incubated
for 24 h at 37uC and in 5% CO2. Both cell lines were exposed to
plumbagin (1, 2.5, and 5 mM for 24 h). The solvent DMSO
treated cells served as control. Cells were then treated with MTT
reagent (10 ml/well) for 4 h at 37uC and then isopropanol (100 ml)
was added to each well to dissolve the formazan crystals. The
optical density (OD) was recorded at 570 nm in a microplate
reader. Percentage of residual cell viability was determined as
[12(OD of treated cells/OD of control cells)]6100.
Effect of plumbagin on PBMC
PBMC was isolated from heparinized venous blood obtained
from a healthy human volunteer by Ficoll-Paque (Histopaque
1077, Sigma Aldrich Inc., USA) density gradient centrifugation as
per standard procedure [19]. PBMC (16105 cells/well) were
cultured in complete RPMI-1640 media as usual and incubated
with plumbagin for 48 h followed by MTT assay.
Cell cycle analysis using flow cytometry
Both HT29 and HCT15 cells were seeded in a 6-well plate at a
density of 1610
5 cells per well. Cells were trypsinized and
harvested by centrifugation at 1700 g. Flow cytometric analysis of
cell cycle was performed by staining of permeabilized cells with
propidium iodide (PI) for DNA content. Cells were resuspended in
PBS, fixed with 70% ethanol, stained with PI solution (0.05 mg/
ml PI, 2 mg/ml RNase A, 0.1% TritonX-100 in PBS) and
incubated for 30 min at room temperature (RT) in darkness.
Fluorescence intensity was measured by flow cytometry (Becton-
Dickinso) using excitation and emission wavelengths of 488
and 525 nm, respectively. All experiments were performed in
triplicates.
Comet assay
The comet assay was performed according to the method of
Singh et al. (1988) [20] with minor modifications. HT29 and
HCT15 cells (5610
5) were seeded into 24-well plates and exposed
to the desired concentrations of plumbagin (the final concentration
of DMSO did not exceed 0.1%, controls were simultaneously
treated with 0.1% DMSO) for specified time periods. Following
treatment, cells were pelleted by centrifugation at 1500 rpm. The
pellet was resuspended in 60 ml of PBS (pH 7.4). 10 ml of cell
suspension was mixed with 100 ml of 1% low melting agarose and
75 ml of this cell–agarose mixture was spread on microscopic slides
precoated with 1% agarose. A third layer of 0.5% low melting
agarose (75 ml) was applied over the layer of agarose with the cell
suspension. Slides were incubated for 1 h in a lysis solution (2.5 M
NaCl, 100 mM Na2EDTA, 10 mM Tris, 1% Triton X- 100, 1%
SDS, pH 10). Subsequently cells were exposed to an alkaline
buffer (300 mM NaOH, 1 mM disodium EDTA) for 30 min. The
microscopic slides were subjected to electrophoresis at 0.8 V/
cm21 for 30 min after which slides were immersed in a
neutralization buffer (0.4 M Tris, pH 7.5) for 15 min. After
staining with ethidium bromide (20 mg/ml) slides were analyzed
under a fluorescence microscope (Nikon PCM-2000). Images of at
least 50 cells from three slides were analyzed using Cometscore
TM
software. For each comet two areas were selected: the whole
cellular DNA and an area containing only the head region of the
comet. In each selection the densities were measured and the
results were presented as tail moment defined as the result of the
percentage of DNA in the tail multiplied by the tail length.
Isolation of RNA
For preparation of total RNA, the phenol – guanidinium
thiocyanate based Tri Reagent (GeNei
TM, Bangalore) was used.
To 10
7 cells, 1 ml of Tri reagent was added and lysed by repetitive
pipetting and allowed to stand for 5 min followed by addition of
200 ml of chloroform for phase separation .Vigorously vortexed for
15 sec and allowed to stand for 15 min followed by centrifugation
at 12000 g for 15 min at 4uC. The upper aqueous layer containing
RNA was transferred to a fresh sterile DEPC treated microfuge
tube. To this, 500 ml of ice cold isopropanol was added, gently
mixed and allowed to stand for 10 min and centrifuged at 12000 g
for 15 min at 4uC. The supernatant was discarded and the RNA
pellet was washed with 1 ml of 75% ethanol in DEPC treated
water and again centrifuged at 14000 g for 10 min at 4uC to get
total RNA. This pellet was dissolved in 25 ml of sterile RNase free
water by heating at 55uC for 20 min and stored at 220uC until
use.
Reverse transcriptase polymerase chain reaction (RT-PCR)
To synthesize cDNA, a reverse transcription reaction solution
containing 1.0 mg total RNA in RNase/DNase-free water and
1.5 ml of random hexamer primer (GeNeiTM, Bangalore) were
incubated for 10 min at 72uC and chilled immediately. To this,
5.0 ml premixed 10 mM dNTP solution (GeNeiTM, Bangalore),
3.0 ml1 0 6 M-MLV reverse transcriptase buffer (GeNeiTM,
Bangalore), 1.0 ml (200 units/ml) M-MLV reverse transcriptase
(GeNeiTM, Bangalore), were added and made up to 50 ml using
sterile RNase/DNase-free water.
To amplify the cDNA, polymerase chain reaction (PCR) ready
mix (GeNeiTM, Bangalore) was used according to manufacturer’s
instruction. All PCR samples were denatured at 94uC for 5 min
prior to cycling and were extended for 10 min at 72uC following
cycling. The PCR assay using primers was performed for 39 cycles
at 94uC for 60 s, 60uC for 60 s, and 72uC for 60 s. Primers for
GAPDH, COX-2, TNF-a are shown in Table 1. Primers were
designed using primer3 software available free on http://fokker.
wi.mit.edu/primer3/input.htm and nucleic acid sequence was
accessed from http://www.ncbi.nlm.nih.gov/entrez/viewer.fci?
val=Reference ID Table. The primers were purchased from
Integrated DNA technologies, USA. Further, expression of COX-
2 and TNF-a was analysed semi quantitatively using UN SCAN
IT software.
Isolation of protein
To 0.5 ml phenol-ethanol supernatant, 3 volumes of acetone
were added to precipitate proteins. Samples were mixed by
inversion for 10–15 sec to obtain a homogeneous solution and
allowed to stand for 10 min at room temperature. Protein was
precipitated by centrifuging at 12,000 g for 10 min at 4uC. The
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guanidine hydrochloride in 95% ethanol with 2.5% glycerol (V:V).
After dispersing the pellet, another 0.5 ml aliquot of the guanidine
hydrochloride/ethanol/glycerol wash solution was added to the
sample and stored for 10 min at room temperature. Protein was
pelleted at 8,000 g for 5 min at 4uC. The wash solution was
removed and two more washes were performed in 1 ml each of the
guanidine/ethanol/glycerol wash solution. Final wash was per-
formed with 1 ml of ethanol containing 2.5% glycerol (V:V).
Protein was pelleted out by centrifuging at 8000 g for 10 min at
4uC and air dried for 5 min. After briefly air-drying, the protein
pellet was dissolved in 1% SDS. Protein concentrations of cell
lysates were estimated according to Lowry et al., 1951 [21] and
equal concentrations of protein fraction were run on sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
and immunobloted with specific antibodies.
siRNA transfection
COX-2 gene was silenced by transfecting COX-2 siRNA. In a
six well tissue culture plate, 2610
5 cells per well were seeded in
2 ml antibiotic-free normal growth medium supplemented with
FBS. Cells were incubated at 37uCi naC O 2 incubator until the
cells were 60–80% confluent. Cell viability was assessed before
transfection. The following solutions were prepared: Solution A:
For each transfection, diluted 6 ml of siRNA duplex (i.e., 0.25–
1 mg or 20–80 pmols siRNA) into 100 ml siRNA Transfection
Medium (Santa cruz, USA). Solution B: For each transfection,
dilute 6 ml of siRNA Transfection Reagent (Santa cruz, USA) into
100 ml siRNA Transfection Medium. siRNA duplex solution
(Solution A) was mixed with diluted Transfection Reagent
(Solution B) and incubate the mixture 45 minutes at room
temperature. For each transfection, 0.8 ml siRNA Transfection
Medium was added to each tube containing the siRNA
Transfection Reagent mixture (Solution A + Solution B), mixed
gently, overlaid onto washed cells and Incubated for 5–7 hours at
37uCi naC O 2 incubator. After incubation, 1 ml of normal
growth medium containing 2 times the normal serum and
antibiotics concentration (26normal growth medium) were added
without removing the transfection mixture. Cells were incubated
for an additional 18–24 hours. Medium was replaced with 1 ml of
fresh 16normal growth medium and used for further assay.
Statistical analysis
Values were recorded as the mean x 6 SD of three experiments.
Experimental results were analyzed by student’s t-test. P,0.00 was
considered as the level of highly significance and P,0.05 was
considered as significance for values obtained for treated groups
compared with control group.
Results
Plumbagin induces cytotoxicity in HCT15 and HT29 colon
cancer cells
Employing HCT15 and HT29 colon cancer cell lines, we first
evaluated the effect of cytotoxicity of plumbagin by MTT assay. In
addition to aberrant Wnt signaling in both cell lines, HT29 cells
are known to express COX2, whereas HCT15 cells lack COX2
expression. Both cell lines were sensitive to plumbagin, indicating
that plumbagin could induce cytotoxicity of both the colon cancer
cells regardless of COX2 status (Fig. 1a and 1b). However,
HCT15 cells were more sensitive to plumbagin as IC50 at 24 hours
was 22.5 mM, which is significantly lower than that of IC50 of
plumbagin treated HT29, which is 62.5 mM. Only non significant
changes in viability of PBMC’s (normal cells) were observed even
in100 mM of Plumbagin incubated cells (Fig. 1c)
Plumbagin inhibits proliferation of HCT15 and HT29
colonic cancer cells
The proliferationof HCT15 cells treated with 15 mM and 30 mM
of plumbagin increased slightly at 24 h and decreased significantly
at 48 h and 72 h, whereas untreated control cells were maintained
exponential growth phase. In contrast, HT29 cells treated with
50 mM plumbagin showed exponential growth, similar to that of
untreated control cells, whereas, the growth of HT29 cells treated
with 75 mM plumbagin increased slightly at 24 h and decreased
significantly at 48 h and 72 h (Fig. 2a and 2b).
Plumbagin induces apoptosis in HCT15 and HT29 colon
cancer cells
To determine the DNA damaging properties of plumbagin,
HCT15cellswereincubatedwith15 mMan d30mMplumbaginfor
24 h, whereas, HT29 cells were incubated with 50 mMa n d7 5mM
plumbagin for 24 h. The appearance of comet tails corresponding
with the induction of DNA damage were visible (Fig. 3). HCT15
cells treated with 30 mM plumbagin and HT29 cells treated with
75 mM plumbagin showed increased extant of DNA damage. The
span of the comet tail was ten and six times that of the control
HCT15 cells and 15 mM plumbagin treated HCT15, respectively,
while, 50 mM and 75 mM plumbagin - treated HT29 cells shows
four and two time of span of tail, respectively, compared to control
HT29 cells. DNA damage was not observed, as the halo
surrounding cell nuclei was clearly visible in control cells.
Analysis of NFkB, Caspase-3 activation and cytochrome C
release in plumbagin incubated HCT15 and HT29 cells
Activation of Caspase-3, NFkB (p65) and cytosolic release of
cytochrome C were analysed by western blotting (Fig. 4a).
Activation of NFkB (p65) was significantly increased in both
15 mM and 30 mM plumbagin - treated HCT15 as well as in
50 mM and 75 mM plumbagin - treated HT29 cells, when
compared to control HCT15 and HT29 cells. Activation of
Caspase-3 and levels of cytosolic cytochrome C were significantly
high, in both 15 mM and 30 mM plumbagin - treated HCT15
cells, when compared to untreated HCT15 cells. However
activation of Caspase-3 and levels of cytosolic cytochrome C were
high only in 75 mM plumbagin treated HT29 cells, but not in
HT29 cells treated with 50 mM plumbagin.
Cell cycle analysis of control and plumbagin treated
HCT15 and HT29 cells
HCT15 cells exposed to 15 and 30 mM of Plumbagin exhibited
continuous increase in sub-G1 fraction which may include both
Table 1. Primer sequence of GAPDH, COX-2 and TNF-a.
S.No. Gene Primer pair
Product
size (bp)
1. GAPDH Left 59- ACAGTCAGCCGCATCTTCTT -39 312
Right 59- TTGATTTTGGAGGGATCTCG -39
2. COX-2 Left - TGAGCATCTACGGTTTGCTG -39 158
Right 59- TGCTTGTCTGGAACAACTGC -39
3 TNF-a Left - CTATCTGGGAGGGGTCTTCC -39 134
Right 59- ATGTTCGTCCTCCTCACAGG -39
doi:10.1371/journal.pone.0018695.t001
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death. The damage was more apparent with 30 mM of Plumbagin.
The sub-G1 fraction for control was 6.8% whereas the same was
24.52 and 37.87% for 15 and 30 mM of Plumbagin treated
HCT15 cells respectively (Fig. 4b.i). This indicates a dose
Figure 1. Effect of Plumbagin on Colonic cancer cells and
normal PBMCs. a. Cytotoxicity effect of various concentrations of
Plumbagin on HCT15 cells. Dose dependent cytotoxicity effects of
Plumbagin on HCT15 cells were represented in the above graph. HCT15
cells were more sensitive to plumbagin as IC50 at 24 hours was 22.5 mM.
All the experiments were done in triplicates and expressed as the mean
6 SD. Significance is indicated as *p,0.001. b. Cytotoxicity effect of
various concentrations of Plumbagin on HT29 cells. Dose dependent
cytotoxicity effects of Plumbagin on HT29 cells were represented in the
above graph. HT29 cells were more sensitive to plumbagin as IC50 at
24 hours was 62.5 mM. All the experiments were done in triplicates and
expressed as the mean 6 SD. Significance is indicated as *p,0.001.
c. Cytotoxicity effect of various concentrations of Plumbagin on PBMC
cells. Dose dependent cytotoxicity effects of Plumbagin on PBMC cells
were represented in the above graph. PBMC cells were resistance to
plumbagin induced cytotoxicity even at 100 mM concentration. All the
experiments were done in triplicates and expressed as the mean 6 SD.
Significance is indicated as *p,0.001.
doi:10.1371/journal.pone.0018695.g001
Figure 2. Effect of different concentrations of Plumbagin on
HCT15 and HT29 cell proliferation. a. HCT15 cells. b. HT29 cells.
Proliferation of HCT15 cells treated with 15 mMa n d3 0 mMo f
plumbagin and HT29 cells treated with 75 mM plumbagin increased
significantly at 48 h and 72 h, whereas , 50 mM plumbagin treated HT29
cells tend to proliferate. All the experiments were done in triplicates and
expressed as the mean 6 SD. Significance is indicated as *p,0.001.
doi:10.1371/journal.pone.0018695.g002
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Results also illustrated associated accumulation of cells in G0/G1
phase, indicating inhibition of movement of cells from G0/G1
phase to S phase, thus delaying or inhibiting the entry of daughter
cells into mitotic cycle.
In case of HT29 cells exposed to 75 mM of Plumbagin alone
exhibited increase in sub-G1 fraction whereas HT29 cells
exposed to 50 mM of Plumbagin sub-G1 fraction was much
lesser. The sub-G1 fraction for control was 4.39% whereas the
same was 6.14 and 26.76% for 50 and 75 mMo fP l u m b a g i n
treated H29 cells respectively, indicating occurrence of extensive
apoptosis only in 75 mM of Plumbagin treated H29 cells, when
compared to 50 mM of Plumbagin treated H29 cells and control
HT29 cells. Results also illustrate that accumulation of cells in
G0/G1 phase only in 75 mM of Plumbagin treated H29 cells,
causing significant decrease in population of S and G2/M phase,
which indicates delay or inhibition of entry of these cells into
synthesis phase and mitotic cycle. Significantly increased cell
population were seen in S and G2/M phase in 50 mMo f
Plumbagin treated H29 cells indicating proliferation of cells
(Fig. 4.b.ii)
Analysis of phosphorylated Akt, phosphorylated EGFR,
PCNA and cyclin D1 in plumbagin incubated HCT15 and
HT29 cells
Expression of PCNA, cyclin D1 along with phosphorylation of
Akt and EGFR was analysed by western blotting (Fig. 5).
Expression of PCNA was significantly decreased in 15 mM and
30 mM plumbagin treated - HCT15 cells when compared with
untreated cells. Significant decrease in levels of PCNA was
observed only in 75 mM plumbagin treated HT29 cells but not in
50 mM plumbagin treated HT29 cells. Significantly decreased
levels of phosphorylated EGFR, Akt and Gsk-3b were observed in
15 mM and 30 mM plumbagin treated HCT15 and in 75 mM
plumbagin treated HT29 cells when compared to control cells. In
50 mM plumbagin treated HT29 cells, levels of phosphorylated
EGFR, Akt and Gsk-3b showed insignificant changes. b - Actin
served as internal control.
Figure 3. Analysis of apoptotic inducing effect of plumbagin on HCT15 and HT29 cells assessed by comet assay. HCT15 cells treated
with 30 mM plumbagin and HT29 cells treated with 75 mM plumbagin showed increased extant of DNA damage. The length of the comet tail was ten
and six times that of the control and 15 mM plumbagin treated HCT15, respectively, while, 50 mM and 75 mM plumbagin - treated HT29 cells shows
four and two time of span of tail, respectively, compared to control HT29 cells. DNA damage was not observed, as the halo surrounding cell nuclei
was clearly visible in control cells.
doi:10.1371/journal.pone.0018695.g003
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HT29 cells treated with plumbagin
Both, 15 mMa n d3 0mM plumbagin - treated HCT15 and
50 mM and 75 mM plumbagin - treated HT29 cells showed
increased amounts of RNA transcripts of the TNF-a gene
compared to the untreated HCT15 and HT29 cells (Fig. 6a).
Levels of RNA transcript of cox-2 was decreased in 75 mM
plumbagin treated HT29 cells, when compared to 50 mM
plumbagin treated HT29 cells, while plumbagin treated
HCT15 cells as well as untreated HCT15 did not show any
expression of cox-2 RNA transcript (Fig. 6c). GAPDH was used as
internal control (Fig. 6b). Comparing control HCT15 and HT29
cells, increased relative expression of TNF-a was seen in both
HCT15 and HT29 cells treated with Plumbagin at both
concentrations while relative expression of cox-2 is significantly
decreased only in 75 mM plumbagin treated HT29 cells, when
compared to 50 mM plumbagin treated HT29 cells (Fig. 6d).
Represented data values were obtained from triplicate analysis
and expressed as the mean 6 SD. Significance is indicated as
*p,0.05;* * p,0.001.
Role of COX-2 in resistance to plumbagin induced
apoptosis in HT29 colon cancer cells
To determine the role of COX-2 in resistance of Plumbagin
induced apoptosis in HT29 colon cancer cells, COX-2 was
silenced and cytotoxicity analysis and cell proliferation was done.
Plumbagin of significantly induced cytotoxicity in COX-2 silenced
HT29 cells in dose dependent manner, where IC50 at 24 hours
was found to be 55.5 mM( Fig. 7.a.i). It also significantly inhibited
cell proliferation in COX-2 silenced HT29 cells compared to
scrambled siRNA transfected HT29 cell incubated with 50 mMo f
Plumbagin (Fig. 7.a.ii).
Figure 4. Plumbagin induces apoptotic in colonic cancer epithelial cells. a. Immunoblotting analysis of NFkB activation, Caspase-3 activation
and cytochrome C release. Lane 1- Control HCT15; Lane 2- 15 mM plumbagin treated HCT15; Lane 3- 30 mM plumbagin treated HCT15; Lane 4- Control
HT29; Lane 5- 50 mM plumbagin treated HT29; Lane 6- 75 mM plumbagin treated HT29. b.i. Cell cycle analysis of control and plumbagin treatment
HCT15 and HT29 cells by Flow Cytometry. Compared with control HCT15, HCT15 treated with plumbagin shows marked rise in sub-G1 fraction
suggesting that these cells are undergoing apoptosis. HT29 cells exposed to 75 mM of Plumbagin alone exhibited increase in sub-G1 fraction whereas
HT29 cells exposed to 50 mM of Plumbagin sub-G1 fraction was much lesser. b.ii. Quantitative data of cell cycle analysis. All the experiments were done
in triplicates and expressed as the mean 6 SD. Significance is indicated as *p,0.001.
doi:10.1371/journal.pone.0018695.g004
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activated cell sorting analysis (FACS). COX-2 siRNA transfected
HT29 cells treated with 50 mM of plumbagin showed 36.78% of
cells in G0G1 phase while 17.64% and 25.88% cells were in S
phase and G2M phase, respectively. 19.86% of plumbagin treated
HT29 cells were undergoing apoptosis (Fig. 7.b.i & Fig. 7.b.ii),
while in scrambled cox-2 siRNA transfected untreated HT29 cells
showed 24.36% of cells were in G0G1 phase while 45.93% and
22.54% of cells were in S phase and G2M, respectively. 3.8% of
control cells were undergoing apoptosis (Fig. 7.b.i & Fig. 7.b.ii).
Relative expression of COX-2 in Plumbagin treated COX-2 si
RNA transfected HT29 cells are significantly (P,0.001) decreased
when compared to scrambled si RNA transfected HT29 cells
treated with Plumbagin (Fig. 7.c).
Synthesis of prostaglandinE2 (PGE2) was unchanged in
Plumbagin treated HCT15 as compared to that of the control
HT15 cells. Significantly (P,0.001) decreased level of PGE2 was
observed in Plumbagin treated COX-2 si RNA transfected HT29
cells when compared with Plumbagin treated HT29 cells and
scrambled si RNA transfected HT29 cells treated with Plumbagin
(Fig. 7.d).
Discussion
Colorectal cancer is the most common neoplasm in human in
both developed and developing countries. Many of chemothera-
peutic agent used is cancer treatment have side effects. On the
other hand, the use of nonsteroidal anti-inflammatory drugs exerts
antitumor effects against CRC [8], however, inflammation favours
proliferation as well as angiogenesis that support the role of
inflammatory mechanisms in growth and progression of CRC.
Traditional medicines, although argued to be harmless and
effective, in most cases neither the chemical entity nor the
molecular mechanisms of action were well defined. Plumbago
zeylanica is once such medicinal plant used traditionally as an anti
inflammatory agent whose mechanism of action has to be
established, particularly in cancer. Plumbagin is an active
compound of Plumbago zeylanica, which has been used as a
chemotherapeutic agent for some of cancer including lung
carcinoma and mylomas. In our study, we have exemplified the
apoptosis inducing ability of plumbagin on two colon cancer cell
lines HCT15 and HT29.
In colon cancer, 90% of the tumor occurs as a result of
activating mutations in the Wnt pathway [22]. Genetic inclination,
such as mutations in adenomatous polyposis coli or b-catenin
causes stabilization and activation of b-catenin, which leads to
uncontrolled proliferation of intestinal epithelial cells through the
constitutively active Wnt-signaling pathway [23,24]. However,
inflammatory mediators such as NFkB, COX and iNOS also play
crutial roles in the development of colon cancer and its
progression.
Cyclooxygenase (COX), known as prostaglandin (PG) H2
synthase, is the rate-limiting enzyme in the conversion of
arachidonic acid into PGs. Overexpression of COX2 has been
frequently observed in colon tumors and COX2 plays a major role
in colon carcinogenesis [25]. Many studies have revealed that
PGE2, the metabolite of COX2, is an effective mitogen, which
contributes to the development of colon cancer and targeting
COX-2 is one recent therapeutic method for treatment of colon
cancer [26,27]. Hence to assess the vital role played by COX2 in
resisting cancer treatment, we employed two colon cancer cell
lines, HCT15 and HT29, where, both the cell lines possess
aberrant Wnt signalling, but expression of COX-2 was seen only
in HT29.
In our study, we demonstrate that in a dose-dependent manner
plumbagin induces cytotoxicity effectively in HCT15 cells when
compared to the HT29 cells. Accordingly, IC50 value of HT29
cells (62.5 mM) was much higher than that of HCT cells
(22.5 mM). Hence, further study was performed by treating cells
with two different concentrations, one concentration fixed well
below the IC50 value (i,e 15 mM and 50 mM of plumbagin for
HCT15 and HT29, respectively) while the other concentration
was fixed above the IC50 (i,e 30 mM and 75 mM of plumbagin for
HCT15 and HT29, respectively). This has been done to study the
response of cancer cells during treatment strategies. However,
plumbagin did not exhibit any significant toxicity on normal cells
(PBMC) at any of the above concentrations, suggesting that
plumbagin possesses selectivity between normal and cancer cells.
Plumbagin alone has been shown to induce apoptosis in
different cell types. Our comet assay data also suggest that both the
concentrations of Plumbagin induce apoptosis in HCT15.
Interestingly, HT29 cells showed resistant to Plumbagin induced
apoptosis at 50 mM concentration which is below the IC50.
However, treatment of 75 mM concentration of Plumbagin
induced apoptosis in HT29 cells. Proliferation of HCT15 cells
was inhibited at both 15 mM and 30 mM concentration of
plumbagin, whereas, Proliferation was inhibited only in 75 mM
plumbagin treated HT29, while, 50 mM plumbagin treated HT29
cells tend to proliferate. PCNA data also confirmed the above fact.
The above fact is attributed to the observed resistance to induction
of apoptosis by Plumbagin in HT29 cells when treated at 50 mM
plumbagin.
Previous reports have suggested that plumbagin induce
apoptosis through the activation of caspases-3 and Cytochrome-
C [16], we examined caspases-3 activation and Cytochrome C
Figure 5. Western blotting analysis of phosphorylated Akt,
phosphorylated EGFR, PCNA and cyclin D1 in control and
plumbagin treated HCT15 and HT29 cells. Lane 1- Control HCT15;
Lane 2- 15 mM plumbagin treated HCT15; Lane 3- 30 mM plumbagin
treated HCT15; Lane 4- Control HT29; Lane 5- 50 mM plumbagin treated
HT29; Lane 6- 75 mM plumbagin treated HT29. Expression of PCNA,
cyclin D1 along with phosphorylation of Akt and EGFR were
significantly decreased in 15 mM and 30 mM plumbagin treated HCT15
and in 75 mM plumbagin when compared to Control HCT15, Control
HT29 and HT29 cells treated with 75 mM plumbagin. b-Actin served as
internal control.
doi:10.1371/journal.pone.0018695.g005
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found to be elevated in 15 mM, 30 mM plumbagin treated HCT15
and 75 mM plumbagin treated HT29 cells. Activation of caspase-3
and release of Cytochrome C by plumbagin are mediated through
over expression of TNF-a. Activation of caspase-3 and Cyto-
chrome C were not significantly observed in 50 mM plumbagin -
treated HT29 cells, even at elevated levels of TNF-a. This result
was interesting, as elevated TNF-a tend to induce apoptosis
through TNFR-death domine receptor [28].
Since the only difference between these two cell lines are COX-
2 and that could mediate a balance between apoptosis and cell
survival, we analysed the expression of COX-2 along with its
transcription factor NFkB. Decreased expression of cox-2 tran-
scripts in 75 mM plumbagin treated HT29 indicates that COX-2
plays a crucial role in plumbagin induced apoptosis. Further, lack
of expression of cox-2 transcripts in control and plumbagin treated
HCT15 authenticates the above facts. However, only non
significant changes were observed in the level of NFkB transcripts.
Figure 6. Expression analysis of TNF-a, COX-2 and GAPDH by RT-PCR. Lane 1- Control HCT15; Lane 2- 15 mM plumbagin treated HCT15;
Lane 3- 30 mM plumbagin treated HCT15; Lane 4- Control HT29; Lane 5- 50 mM plumbagin treated HT29; Lane 6- 75 mM plumbagin treated HT29. a.
Plumbagin - treated HCT15 and HT29 cells showed increased amounts of RNA transcripts of the TNF-a gene compared to the untreated HCT15 and
HT29 cells. b. Levels of RNA transcript of cox-2 was decreased in 75 mM plumbagin treated HT29 cells, when compared to 50 mM plumbagin treated
HT29 cells, while plumbagin treated HCT15 cells as well as untreated HCT15 did not show any expression of cox-2 RNA transcript. c. Showing level of
GAPDH RNA transcripts in control and Plumbagin - treated HCT15 and HT29 cells. d. Represents densitometric analysis showing relative expression of
TNF-a and cox-2 to GAPDH. Represented data values were obtained from triplicate analysis and expressed as the mean 6 SD. Significance is indicated
as *p,0.05;* * p,0.001.
doi:10.1371/journal.pone.0018695.g006
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PLoS ONE | www.plosone.org 9 April 2011 | Volume 6 | Issue 4 | e18695As COX-2 is regulated by activated NFkB, we analysed
activation NFkB by immuno blotting with p65 specific antibodies.
Our results indicate that NFkB activation was found elevated in
Plumbagin treated HCT15 and HT29 cells at both the
concentrations. Activation of NFkB (p65) is due to elevated levels
of TNF-a through TRADD-TRAF. Expression of COX-2 is
decreased even at high levels of p65 (activated NFkB) which cloud
be due to the fact that plumbagin modulates p65 by targeting
Cystine-38. Modification of Cystine-38 in p65 affects its DNA
binding capacity [16].
Studies in human cancer indicate that use of specific COX2
inhibitors may be an effective approach for colorectal cancer
prevention and treatment [1,29]. PGE2 is a metabolite of COX-2
and an important downstream target of PGE2 is the epidermal
growth factor receptor (EGFR) pathway that has also been
implicated in colon carcinogenesis [30]. Hence we analysed
phosphorylated EGFR and one of its downstream targets Akt.
Increased levels of phosphorylated EGFR and Akt in 50 mM
plumbagin treated HT29 cells is contributed by COX-2, thus
offering resistance to plumbagin induced apoptosis.
Activation of Akt inhibits Gsk-3b and causing accumulation of
cyclin D1 leading to loss of cell cycle regulation [31–33]. 15 mM,
30 mM plumbagin treated HCT15 and 75 mM plumbagin treated
HT29 cells, cells will be arrested at G0/G1 phase due to
degradation of cyclin D1 by active Gsk-3b as Akt in its inactive
form may be due to unavailability of COX-2 dependent PGE2.
Akt is still active due to COX-2 dependent phosphorylation of
EGFR through PGE2 in 50 mM plumbagin treated HT29 cells
showing accumulation of cyclin D1 causing cell cycle disregulation
and forms the basis for cell proliferation even with 50 mM
plumbagin. Further, increased apoptosis Sub-G1 population and
increased cytotoxicity associated with decrease levels of PGE2 in
50 mM Plumbagin treated COX-2 si RNA transfected HT29 cells,
authenticate that the COX-2 plays crucial role in resisting
Plumbagin induced apoptosis of HT29 cells
Taken into all above facts, we conclude that induction of
apoptosis in colonic cancer cells by plumbagin is mediates through
TNF-a expression and TNF-a mediated pathway by activating
Caspase-3 and releasing of Cytochrome C. However, balance
between cell survival and apoptosis controlled by COX-2.
Modulation of p65 (NFkB) by Plumbagin inhibits cell survival
through inhibiting of phosphorylation of EGFR, Akt and GSK-3b
and shifts the balance towards apoptosis.
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